Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info: https://youtu.be/811v7RLXP9M
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country
MEBO TMAU TESTING DISCONTINUED
(2012-2017)

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO survey for Dr Hazen click here
Read more/less

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

MEBO Research Clinical Trials

Monday, August 11, 2014

RE(ACT) TMAU project submitted by Dr John Christodoulou

Dr John Christodoulou TMAU project
Dr John Christodoulou
REA(CT) TMAU project has been submitted

We can inform you that a TMAU project has be submitted to the RE(ACT) rare disease crowdfunding platform :

by Dr John Christodoulou et al of Sydney Australia
It will now be reviewed by the RE(ACT) Scientific committee (expected time : 3-5 weeks)
NOTE : As it is exploratory it may not be approved by the committee

Project :
It has 2 parts :
1. is to use Ataluren to see if it improves nonsense mutation TMAU cases. This is a severe type of mutation and most sufferers probably do not have nonsense mutations (about 10% are estimated to have nonsense mutations).
TMAU project
2. To see if a microbe 'methylophilus methotropholus' could be used as a specific 'probiotic' for TMAU patients as it may neutralize trimethylamine in the gut. This should in theory helkp all TMAU sufferers.

Time and Cost :
The study would be expected to take 3 years, with 2 professionals being employed especially to conduct the study.
The cost would be around $AUS 473,000 plus RE(ACT) admin fees of 10% (current estimate)
The study would presumably take place in Australia

We will elaborate more over the days and weeks on the project, but basically all the info of the project is in the photo on the right, which is a copy of the document submitted.

To the right is Professor Christodoulou's career summary

Click to read project in full (pdf hosted on MEBO website)
Dr Christodoulou TMAU project  

Dr Christodoulou career summary 
(pdf hosted on MEBO website)

Other links :
RE(ACT) TMAU Group
Dr Christodoulou researcher listed on RE(ACT)

0 comments:

Post a Comment